Mesa Laboratories, Inc.
A maker of quality-control tools for hospitals, labs, and pharmaceutical companies, Mesa Laboratories builds biological indicators—like its EZTest and Smart-Read lines—that verify sterilization equipment actually kills germs. Founded in Lakewood, Colorado in 1982, it grew from a small instrumentation and calibration shop into a global player through steady acquisitions, including Agena Bioscience and GKE. The name nods to the flat-topped hills common across its home state, a fitting touch for a company rooted in the American West.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Long Path Smaller Companies Fund, LP | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| Long Path Fund GP, LLC | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| Long Path Partners, LP | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| Long Path Holdings LLC | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| William Thomas Brennan | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| Brian Paul Nelson | 13G/APassive | 8.6% | 477.1K | Jul 7, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| BlackRock, Inc. | 13G/APassive | 6.9% | 378.9K | Oct 2, 2025 |
| ROYCE & ASSOCIATES LP | 13G/APassive | 4.99% | 271.1K | Apr 30, 2025 |
| Conestoga Capital Advisors | 13G/APassive | 11.38% | 618.1K | Jan 10, 2025 |